Movement Disorders · 2014 · 86 citations · 161 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyNeuropsychiatryNeuropsychologyDeep Brain StimulationDopaminergic PharmacologyParkinson DiseaseParkinsonian DisordersDisease-related Behavioral ChangesDopamine Dysregulation SyndromeNeuropsychiatric EffectsNeuropsychiatric ManifestationsParkinson's Disease PharmacotherapyParkinsonism ImagingParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment
In recent years, levodopa-induced behavioral changes have received increased attention in the medical literature and in clinical practice. The spectrum of these symptoms includes non-motor fluctuations with neuropsychiatric symptoms, compulsive behaviors such as punding, dopamine dysregulation syndrome, and impulse control disorders, psychosis and hallucinations, as well as hypomania and mania. Despite knowledge of the clinical features associated with these behaviors, many of them are probably underdiagnosed. Although the mechanisms underlying behavioral symptoms are still incompletely understood, recent data from imaging and pathological studies have increased our understanding and guided new treatment strategies. Appropriate management remains challenging, because reduction of levodopa (l-dopa) and dopaminergic treatment is often recommended; however, doses required for control of motor symptoms may still induce behavioral changes. Newer modes of delivery of dopaminergic treatment, deep brain stimulation, and nondopaminergic agents may either provide alternatives for treatment of these behavioral problems or permit treatment of parkinsonism with less risk of these behavioral disorders.
161
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Julian Fearnley, Andrew J. Lees · Brain · 1991 · 3.5K citations
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
M. A. Hely, Wayne G.J. Reid, Michael Adena et al. · Movement Disorders · 2008 · 2.2K citations · Full text
Medicine, Neurology, Neuroscience +12
Impulse Control Disorders in Parkinson Disease
Daniel Weintraub, Juergen Koester, Marc N. Potenza et al. · Archives of Neurology · 2010 · 1.5K citations
Medicine, Neurology, Psychiatry +15
Rivastigmine for Dementia Associated with Parkinson's Disease
Murat Emre, Dag Aarsland, Alberto Albanese et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Gilles Fénelon · Brain · 2000 · 1K citations
Medicine, Neurology, Psychiatry +13